choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Exforge

Exforge Newsletter
  • Nigerians worry about survival amid soaring prices of drugs, food 11 Feb 2024 16:17 GMT

    … and over-the-counter medications have witnessed a steady … August 2023 and Sanofi pharmaceutical multinational in November 2023 … in drugs, especially high-blood drugs, was alarming. ” I bought Exforge … said the increase in medication costs posed challenges for …

  • Nigerians decry increase in prices of medications 11 Feb 2024 14:32 GMT

    … in August 2023 and Sanofi pharmaceutical multinational in November 2023 from … increase in drugs, especially high blood drugs was alarming. ” I bought Exforge in … Journalists, said the increase in medication costs posed challenges for individuals …

  • Novartis to pay $245 million to end antitrust cases over Exforge drug generics 29 Dec 2022 02:37 GMT

    … of generic versions of its Exforge hypertension drug. The settlements with so … Endo International Plc’s Par Pharmaceutical unit. Novartis and Par were accused … market. Novartis’s annual U.S. sales of brand-name Exforge exceeded …

  • Novartis to pay $245 million over Exforge drug generics 29 Dec 2022 02:43 GMT

    … YORK (Reuters) – Novartis AG said on Wednesday … litigation accusing the Swiss drugmaker of trying to delay … generic versions of the Exforge blood pressure treatment. The settlements with … the company over the matter, Novartis said. (Reporting by Jonathan …

  • Novartis to pay $245 mln to end antitrust cases over Exforge drug generics 29 Dec 2022 00:48 GMT

    … gene therapy factory of Swiss drugmaker Novartis in Stein, Switzerland, November 28 … of generic versions of its Exforge hypertension drug. The settlements with so … ;s (ENDPQ.PK) Par Pharmaceutical unit. Novartis and Par were accused of …

  • High drug prices: APC chieftain seeks Tinubu’s intervention 18 Dec 2023 07:53 GMT

    … , a major player in the pharmaceutical industry, the high rate of … Amlodipine, Augmentin, Paracetamol, Exforge, Coartem, and other essential drugs to become unaffordable … incurred in procuring these essential medical supplies rise, consequently driving up …

  • APC chieftain implores Tinubu to intervene in high drug prices  18 Dec 2023 04:04 GMT

    … a major player in the pharmaceutical industry, high rate of inflation … amlodipine, augmentin, paracetamol, exforge, coartem, and other essential drugs to become unaffordable … incurred in procuring these essential medical supplies rise, consequently driving up …

  • Tackle high cost of drugs, APC chief tells Tinubu 18 Dec 2023 03:47 GMT

    … , a major player in the pharmaceutical industry, the high rate of … amlodipine, augmentin, paracetamol, exforge, Coartem, and other essential drugs to become unaffordable … incurred in procuring these essential medical supplies rise, consequently driving up …

  • Hike in drug prices: APC Chieftain calls for President Tinubu urgent intervention 17 Dec 2023 12:01 GMT

    … , augmentin, paracetamol, exforge, Coartem, and other essential drugs to become unaffordable … incurred in procuring these essential medical supplies rise, consequently driving … more enabling environment for the pharmaceutical company. He commended Prof. …

  • NAFDAC alerts public to Parallel importation of unregistered Novartis Prescription Medicines at Muritala Mohammed Airport, Ikeja 04 Dec 2023 13:09 GMT

    … of certain Novartis Prescription-Only-Medicines (POM) brands … of Parlodel Tablets, Exforge HCT Tablets, Glucophage … sale of medications, including counterfeit drugs, poses a … and sale of unregistered pharmaceuticals. Importers, distributors, retailers …

Satisfied with the content?

Continue to create your account.